What's new

Human medicines European public assessment report (EPAR): Prolia, denosumab, Date of authorisation: 26/05/2010, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Prolia, denosumab, Date of authorisation: 26/05/2010, Revision: 33, Status: Authorised

Jun 18, 2025 - 16:25
 0
Human medicines European public assessment report (EPAR): Prolia, denosumab, Date of authorisation: 26/05/2010, Revision: 33, Status: Authorised
Human medicines European public assessment report (EPAR): Prolia, denosumab, Date of authorisation: 26/05/2010, Revision: 33, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Doptelet, avatrombopag...

Next Article

Questions and answers clinic on Product Management Service (PMS) Product User In...

Related Posts

Human medicines European public assessment report (EPAR): Rytelo, imetelstat, Date of authorisation: 07/03/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Ristfor, sitagliptin,metformin hydrochloride, Date of authorisation: 15/03/2010, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Tecvayli, teclistamab, Date of authorisation: 23/08/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 4, 2025  0